CGRP Antagonist Synthesis via Segmented Crystallization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing compounds with CGRP-antagonistic properties face challenges in efficient purification and separation of enantiomers, particularly in the stepwise synthesis from compounds of general formulae III and IV.

Innovation Solution

A process involving coupling of compounds of general formula III with IV in the presence of a strong base, followed by crystallization and optional recrystallization, to produce compounds of general formula II, which are then used to synthesize compounds of general formula I with CGRP-antagonistic properties, utilizing specific solvents and conditions to achieve purified intermediates.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional synthesis methods are used for compounds with CGRP-antagonistic properties, then the synthesis can be performed, but purification and separation of enantiomers becomes inefficient and difficult

Engineering Contradiction:
Improvepurification efficiencyVSAvoidsynthesis efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The synthesis is divided into discrete stepwise stages with isolated intermediate compounds (formulae III, IV, II, I) that can be individually purified and characterized. Each coupling step targets a specific transformation, allowing for systematic optimization of purification at each stage rather than dealing with complex mixtures throughout the entire synthesis process.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method prepares and isolates intermediate compounds (formulae III and IV) with specific stereochemistry and purity before the final coupling step. This preliminary preparation of well-defined intermediates enables more efficient final purification and enantiomer separation compared to attempting to purify the entire synthesis mixture at once.

Inventive Principle:
Principle #10Preliminary action

2Manufacturing precision

If stepwise synthesis from compounds of general formulae III and IV is employed, then purification becomes easier through crystalline intermediates, but the synthesis process becomes more complex

Engineering Contradiction:
Improvepurification easeVSAvoidsynthesis process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The overall synthesis is segmented into distinct stages with isolable intermediate compounds that crystallize in defined forms. This segmentation transforms a complex one-step synthesis into manageable sequential steps, where each stage's complexity is reduced by the purification advantage provided by crystalline intermediates.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method exploits changes in physical parameters (crystallization behavior, solubility, melting point) of intermediate compounds to achieve purification. By controlling crystallization conditions for intermediates of formulae III, IV, and II, the process leverages parameter changes to simplify purification despite the multi-step nature of the synthesis.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process allows for the isolation of crystalline intermediates, facilitating purification and enantiomer separation, thereby enhancing the synthesis efficiency of compounds with CGRP-antagonistic properties.

Implementation Method 1

coupling a compound of general formula III to a compound of general formula IV

Methodology Applied
Scientific EffectCoupling reaction: Chemical Bonding

Implementation Method 2

isolating a compound of general formula II obtained in step (a), preferably by crystallisation, from a solvent

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Data Source

PatentUS8119797B2Production method
Publication Date: 2012.02.21 BOEHRINGER INGELHEIM INT GMBH
  • US8119797B2 patent drawing
  • US8119797B2 patent drawing
  • US8119797B2 patent drawing

AI summary

The present invention relates to a process for preparing compounds of general formula Iwherein R1 and R2 are defined as in claim 1, the pharmaceutically acceptable salts and the solvates thereof, which may be prepared starting from compounds of general formula IIwherein R1 is defined as in claim 1.